Algunos estados en EE. UU. afirman que no pueden costear Ozempic y otros medicamentos para perder pesonews2024-06-29T16:11:41+00:00June 29th, 2024|The New York Times|
Purdue Opioid Settlement on Verge of Collapse After Supreme Court Rulingnews2024-06-27T19:56:56+00:00June 27th, 2024|The New York Times|
Some States Say They Can’t Afford Ozempic and Other Weight Loss Drugsnews2024-06-25T21:09:10+00:00June 25th, 2024|The New York Times|
National Academies Members Demand Answers About Sacklers’ Donationsnews2023-04-28T16:36:40+00:00April 28th, 2023|The New York Times|
McKinsey Guided Companies at the Center of the Opioid Crisisnews2022-06-29T23:24:22+00:00June 29th, 2022|The New York Times|
Lawmakers Dismiss McKinsey’s Apology on Opioid Crisis as ‘Empty’news2022-04-27T22:34:40+00:00April 27th, 2022|The New York Times|
McKinsey Opened a Door in Its Firewall Between Pharma Clients and Regulatorsnews2022-04-13T22:06:06+00:00April 13th, 2022|The New York Times|
Tribes Reach $590 Million Opioid Settlement With Johnson & Johnsonnews2022-02-01T22:52:05+00:00February 1st, 2022|The New York Times|
Judge Overturns Purdue Pharma’s Opioid Settlementnews2021-12-17T12:52:42+00:00December 17th, 2021|The New York Times|
Judge Overturns Purdue Pharma’s Opioid Settlementnews2021-12-17T12:52:42+00:00December 17th, 2021|The New York Times|
